North America Blood Transfusion Diagnostics Market Forecast to 2028

Report Code : BMIRE00027389 | Region : North America | Industry : Medical Device | Published Date : 09/Nov/2022
North America Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)

The North America blood transfusion diagnostics market is expected to grow from US$ 1,815.82 million in 2022 to US$ 2,742.80 million by 2028. It is estimated to grow at a CAGR of 7.1% from 2022 to 2028.

Need for Blood Transfusion due to Rise in Organ Transplants Surgeries Drives Market Growth

Organ transplantation is a surgical procedure performed in case of failure of organs such as heart, liver, and kidney. The rising cases of chronic diseases, such as chronic kidney disease (CKD), polycystic kidney disease, cystic fibrosis, and congenital heart disease, are triggering the number of organ transplant surgeries performed. These procedures generally take hours, and a lot of blood is lost during the procedure, which leads to the requirement for blood transfusion. The public-private partnership, in collaboration with transplant coordinators, has significantly contributed to the improvement of organ transplants that require a constant need for blood transfusion. The number of organ transplant surgeries has surged in, both, developing and developed countries. Healthcare sectors in developing countries, which are gathering large attention as medical tourism destinations, are undergoing continuous advancements, which allows them to provide better and more modern medical treatments. The rising need for organ transplants is a key factor driving the demand for blood transfusion diagnostics across North America.

Market Overview

The North America blood transfusion diagnostics market has been segmented into the US, Canada, and Mexico; the US is the largest contributor to the market in this region. The blood transfusion diagnostics market growth in North America is attributed to the rising number of surgical procedures for chronic health conditions. Per the American National Red Cross Organization, 2022, ~29,000 units of red blood cells; ~5,000 units of platelets; and ~6.500 units of plasma are needed daily in the US. ~16 million blood components are transfused each year in the US. A car accident victim may require as many as 100 units of blood. According to data published by the American Academy of Orthopedic Surgeons in 2018, orthopedic surgeries are among the most commonly performed procedures in the world. Studies conducted by the American Academy of Orthopedic Surgeons estimated that the number of total joint replacement (TJR) procedures is likely to surge by 171% by 2030, while total knee replacement procedure count is expected to surge by 189%, reaching ~635,000 and 1.28 million, respectively. Thus, with the elevating number of patients undergoing orthopedic surgeries, the demand for blood transfusion is also rising, thereby boosting the blood transfusion diagnostic market in North America.

North America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

North America Blood Transfusion Diagnostics Market Segmentation

The North America blood transfusion diagnostics market is segmented based on product, application, end user, and country. Based on product, the market is bifurcated into instruments & kits and reagents. The instruments & kits segment held a larger market share in 2022. on the basis of application, the North America blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held a larger market share in 2022. In terms of end user, the North America blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment dominated the market in 2022. The North America blood transfusion diagnostics market, by country, has been classified as the US, Canada, and Mexico; the US dominated the market in 2022.

Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the North America blood transfusion diagnostics market.

The List of Companies - North America Blood Transfusion Diagnostics Market

● Abbott

● BAG Diagnostics GmbH

● Bio-Rad Laboratories, Inc.

● DiaSorin S.p.A.

● F. Hoffmann-La Roche Ltd   

● Grifols, S.A.

● Immucor, Inc.

● Ortho Clinical Diagnostics (QuidelOrtho Corporation)

● Quotient Limited

● Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Blood Transfusion Diagnostics Market – By Product

1.3.2 North America Blood Transfusion Diagnostics Market – By Application

1.3.3 North America Blood Transfusion Diagnostics Market – By End User

1.3.4 North America Blood Transfusion Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Blood Transfusion Diagnostics Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Blood Transfusion Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rapid Rise in Chronic Diseases

5.1.2 Growing Need for Blood Transfusion due to Rise in Organ Transplants Surgeries

5.2 Market Restraints

5.2.1 Problems associated with Blood Transfusion Services

5.3 Market Opportunities

5.3.1 Elevated Healthcare Expenditure in Emerging Economies

5.4 Future Trends

5.4.1 Technological Developments in Blood Transfusion Diagnostics

5.5 Impact Analysis

6. Blood Transfusion Diagnostics Market– North America Analysis

6.1 North America Blood Transfusion Diagnostics Market Revenue Forecast and Analysis

7. North America Blood Transfusion Diagnostics Market Analysis – By Product

7.1 Overview

7.2 North America Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)

7.3 Instruments and Kits

7.3.1 Overview

7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

7.4 Reagents

7.4.1 Overview

7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8. North America Blood Transfusion Diagnostics Market Analysis – By Application

8.1 Overview

8.2 North America Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)

8.3 Disease Screening

8.3.1 Overview

8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8.4 Blood Grouping

8.4.1 Overview

8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9. North America Blood Transfusion Diagnostics Market Analysis – By End User

9.1 Overview

9.2 North America Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)

9.3 Blood Banks

9.3.1 Overview

9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.4 Hospitals

9.4.1 Overview

9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.6 Plasma Fractionation Companies

9.6.1 Overview

9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

10. North America Blood Transfusion Diagnostics Market Analysis – Country Analysis

10.1 Overview

10.1.2 North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 US: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.1.2.1.3 US: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 US: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Canada: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.1.2.2.3 Canada: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Canada: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.2.3 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 Mexico: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.1.2.3.3 Mexico: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 Mexico: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Grifols, S.A.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Immucor, Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bio-Rad Laboratories, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Abbott

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Thermo Fisher Scientific Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 DiaSorin S.p.A.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Quotient Limited

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 BAG Diagnostics GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Mn)

Table 2. US: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3. US: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4. US: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5. Canada: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 6. Canada: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 9. Mexico: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 10. Mexico: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Recent Inorganic Growth Strategies

Table 12. Recent Organic Growth Strategies

Table 13. Glossary of Terms

The List of Companies - North America Blood Transfusion Diagnostics Market

● Abbott

● BAG Diagnostics GmbH

● Bio-Rad Laboratories, Inc.

● DiaSorin S.p.A.

● F. Hoffmann-La Roche Ltd   

● Grifols, S.A.

● Immucor, Inc.

● Ortho Clinical Diagnostics (QuidelOrtho Corporation)

● Quotient Limited

● Thermo Fisher Scientific Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America blood transfusion diagnostics market.

● Highlights key business priorities to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the blood transfusion diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(North America Blood Transfusion Diagnostics Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry